Loading...
Market
What will be the outcome of US toolmakers' lobbying against Huawei restrictions by December 31, 2024?
2
Biden•Huawei•American•Chinese•House China Committee•US•Lam Research•Applied Materials•KLA•AMD•Nvidia•Apple•TSM•Intel•US Congress•China
Resolution / Starting Odds
Restrictions eased • 25%
Restrictions maintained • 25%
Restrictions strengthened • 25%
No decision • 25%
Reports or announcements from US government or industry groups
Story
House China Committee Pushes to Block Huawei from Buying US Chipmaking Gear
Oct 16, 2024, 06:35 PM
Key lawmakers are pressing the Biden administration to block Huawei from buying American chipmaking gear, escalating efforts to prevent the sanctioned Chinese telecom giant from making progress on semiconductor manufacturing. The bipartisan House China Committee is advocating for these restrictions, emphasizing the need to cut off Huawei vendors from US chip gear. American toolmakers such as Lam Research, Applied Materials, and KLA have lobbied against further curbs without comparable measures from allies. This move is expected to impact major US chip companies including AMD, Nvidia, Apple, TSM, and Intel. US Congress is expected to cut off Huawei vendors and China from additional US chip gear, as indicated in a letter from House China Committee members.
View original story
Similar markets
No violation found • 25%
Violation found, no sanctions • 25%
Violation found, sanctions imposed on TSMC • 25%
Violation found, sanctions imposed on Huawei • 25%
No Violation Found • 25%
Violation Found, No Penalty • 25%
Violation Found, Minor Penalty • 25%
Violation Found, Major Penalty • 25%
Restrictions approved • 25%
Restrictions rejected • 25%
No decision • 25%
Compromise reached • 25%
No Violation Found • 25%
Minor Violation, No Penalty • 25%
Major Violation, Penalty Imposed • 25%
Investigation Inconclusive • 25%
Tariffs implemented • 25%
Tariffs blocked • 25%
Tariffs modified • 25%
No change • 25%
Major revenue decline • 25%
Minor revenue decline • 25%
No significant impact • 25%
Revenue growth • 25%
Impose limits • 25%
No action taken • 25%
Postponed decision • 25%
Other measures • 25%
Resolution reached • 25%
Stalemate • 25%
Escalation of tensions • 25%
No significant progress • 25%
New restrictions implemented • 25%
Current restrictions maintained • 25%
Restrictions relaxed • 25%
No change in policy • 25%
Yes • 50%
No • 50%
